If you liked this article you might like

Pricing Stress may Weigh on Generic Drugmakers Ahead of Q2 Earnings
Analysts Differ On Impact Of Valeant's Rejected Takeover Bid
5 Stocks Set to Soar on Bullish Earnings
Today's Dead Cat Bounce Stock Is Akorn (AKRX)